期刊文献+

直链淀粉手性固定相拆分西那卡塞对映体 被引量:1

Enantiomeric separation of cinacalcet on amylase chiral stationary phase by high performance liquid chromatography
下载PDF
导出
摘要 建立了一种快速、准确的高效液相色谱分析方法。使用Chiralpak AD-H手性色谱柱,检测波长224nm,考察了流动相中极性调节剂的体积分数、流动相中三乙胺的体积分数、柱温及流速对西那卡塞对映体拆分的影响。确立了最佳拆分条件:流动相为正己烷-异丙醇-三乙胺(90∶10∶0.1,V/V/V);流速为1.0 m L·min-1;柱温为30℃。在此优化实验条件下,得到西那卡塞对映体的出峰顺序为:先S体,后R体。所建立的方法简单准确,重复性好,可用于西那卡塞的质量研究和控制。 A quantitative analysis method for the determination of cinacalcet enantiomers by HPLC had been developed.The enantiomers of cinacalcet were separated on a Chiralpak AD-H column and the UV detection wavelength was 224 nm.The influences of concentration of organic solvent,proportion of triethylamine,column temperature and flow rate on the enantiomeric separation were investigated.The optimal chromatographic conditions were as follows: the mobile phase was hexane-isopropanol-triethylamine(90 ∶10∶0.1,V/V/V);the flow rate was 1.0 m L·min-1;the column temperature was 30℃.Under the optimal conditions,the elution order of two enantiomers was S-cinacalcet before R-cinacalcet.It was simple,accurate,and reproducible HPLC method,and could be used for the analysis and quality control of cinacalcet.
出处 《化学研究与应用》 CAS CSCD 北大核心 2015年第6期882-885,共4页 Chemical Research and Application
关键词 西那卡塞 对映体拆分 Chiralpak AD-H 高效液相色谱 cinacalcet enantiomeric separation Chiralpak AD-H HPLC
  • 相关文献

参考文献10

  • 1Chaim Charytan,Jack W. Cobum, Michel Chonchol ,et al. Cinacalcet hydrochloride is an effective treatment for sec- ondary hyperparathyroidism in patients with CKD not re- ceiving dialysis [ J ]. Am J Kidney Diseases, 2005,46 ( 1 ) : 58-67.
  • 2张明清.FDA批准首个拟钙剂西那卡塞[J].上海医药,2004,25(7):329-330. 被引量:6
  • 3T.塞凯赖什,J·雷帕希,A·绍博,等.制备西那卡塞盐酸盐及其多晶型形式的方法[P].CN:101522606A,2009-09-02.
  • 4Glenn M Chertow, Samuel Blumenthal, Stewart Turner, et al. Cinacalcet hydrochloride(sensipar) in hemodialysis pa- tients on active vitamin D derivatives with controlled PTH and elevated calcium x phosphate[ J ]. Clin Am So Neph- rology ,2006 ,1 (2) :305-312.
  • 5Dr Desmond Padhi, Robert Harris. Clinical pharmacokinet- ic and pharmacodynamic profile of cinacalcet hydrochlo- ride [ J ]. Clin Pharmacokinetics, 2009,48 ( 5 ) : 303-311.
  • 6Nemeth EF, Heaton WH, Miller M, et al. Pharmacodynam- ics of the type II catcimimetic compound cinacalcet HC1 [ J]. Pharmacol Exp Ther,2004,308:627-635.
  • 7Shalhoub V, Grisanti M, Padagas J, et al. In vitro studies with the calcimimetic, cinacalcet HC1, on normal human a- dult osteoblastic and osteoclastic cells [ J ]. Crit Rev Eu- karyotic Gene Expression ,2003,13:89-106.
  • 8Vadde Ravinder, Sigala Ashok, M. Satish Varma, et al. A validated chiral LC method for the enantiomeric separation of cinacalcet hydrochloride [ J ]. Chromatographia, 2009, 70:229-232.
  • 9Ravi Bhushan, Rituraj Dubey. Indirect reversed-phase high-performance liquid chromatographic and direct thin- layer chromatographic enantioresolution of( R, S) -cinacal- cet [ J ]. Biomed Chromatogr ,2011,25 (6) : 674-679.
  • 10邵保海,徐秀珠,吕建德,等.纤维素衍生物手性固定相用于高效液相色谱对映体分离[J].分析化学,2003,31(2);239-244.

共引文献6

同被引文献10

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部